Tesaro’s ovarian cancer drug Zejula has been recommended by EU regulators, a competitor to AstraZeneca's trailblazing Lynparza. Zejula (niraparib), from the poly-adipose ribose polymerase (PARP ...

We may earn commission from links on this page, but we only recommend products we back.

Tesaro UK used one particular type of fingerprint to demonstrate that their potential orphan drug Zejula was markedly dissimilar to two existing orphan drugs for the treatment of specific forms of ...

Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China. Oct 25 5:36am ET Zai ...

Tesaro’s ovarian cancer drug Zejula has been recommended by EU regulators, a competitor to AstraZeneca's trailblazing Lynparza. Zejula (niraparib), from the poly-adipose ribose polymerase (PARP ...